Doctor

New hope from the first implant performed at the Careggi Hospital in Florence.

Stargardt's disease is a rare form of degenerative retinal disease, which affects, on a hereditary basis, one in 10,000 people. It is, like Retinitis Pigmentosa, a degenerative maculopathy......

Alzheimer's, ALS and Parkinson's possible consequences of glaucomatous disease.

Professors Paolo Frezzotti and Nicola De Stefano of the University of Siena presented the results of the research they conducted on Wednesday 15 June at the 'Giovanni Spadolini' Senate Library......

Prof. Maurizio Rolando tells us about 0.2% hyaluronic acid as a protective therapy against the side effects of topical anti-glaucoma therapy

[caption id="attachment_2736" align="alignright" width="300"] Maurizio Rolando[/caption] Medical therapy for glaucoma is characterised by the continuous use of one or more topical preparations that must be instilled regularly, one or more......

The non-invasive approach to the patient.

The treatment of AMD and many macular diseases, which can severely impair central vision, has undergone a revolution in the last decade due to the increasing use of intra-vitreal therapies.......

The correction of astigmatism is one of the most important goals of refractive cataract surgery today.
Dr. Scipione Rossi presents an overview of functional problems and technological solutions.

For a summary of the salient points, we provide the presentation. "TORICAL IOLS: functional problems and technological solutions" AICCER- Rome, 12 March 2016 Scipione Rossi Director UOC Ophthalmology......

Ever-increasing attention and research efforts.

Rare diseases are undoubtedly a major challenge for the health systems of all developed countries, even those with welfare and healthcare systems......

New steps in the training of young ophthalmologists

Phacoemulsification and intraocular lenses (IOLs) marked a revolution in cataract surgery several decades ago: in 1967 Charles D. Kelman performed the first phacoemulsification, while Harold......

Molecular editing to obtain biocompatible organs and tissues from animals.

The gap between the waiting lists of those in need of an organ and the number of organs actually available for transplantation is still very large and threatens to......